Preeclampsia’s unique pathophysiology, characterized by endothelial dysfunction, angiogenic imbalance (elevated sFlt-1/PlGF ratio), and intravascular volume contraction, amplifies this risk (6–9). This evidence concerns the gene PGF and preeclampsia.